Gastroenterology
Conference Coverage
GI symptoms and chronic fatigue may persist months after COVID-19
Loose stools, somatization, and chronic fatigue risks increased at a mean of 5 months after SARS-CoV-2 infection, suggesting a common...
FDA/CDC
FDA restricts obeticholic acid (Ocaliva) over serious liver injury risk
Before starting obeticholic acid, clinicians should determine whether a patient with PBC has advanced cirrhosis.
Conference Coverage
Pandemic colonoscopy restrictions may lead to worse CRC outcomes
"Recovery of the colonoscopy backlog is going to be a challenge that will take a while - maybe even years - to resolve," Dr. Jill Tinmouth...
News
USPSTF final recommendation on CRC screening: 45 is the new 50
“There are many tests available that can effectively screen for colorectal cancer and the right test is the one that gets done,” said Dr. Martha...
News
FDA OKs nivolumab after surgery for esophageal or GEJ cancer: Practice-changing use of immunotherapy
A 1-year course of adjuvant nivolumab did not negatively impact patient-reported quality of life, the trialists reported.
FDA/CDC
FDA okays upfront pembro for advanced HER2+ gastric cancer
The accelerated approval is for first-line use in combination with other agents for locally advanced unresectable or metastatic HER2-positive...
FDA/CDC
FDA to recommend limits on heavy metals in baby foods
Called “Closer to Zero,” the FDA plan calls for continued scientific investigation, establishes acceptable levels of heavy metals, sets up a way...
News
FDA approves first AI device to detect colon lesions
The GI Genius works in conjunction with an endoscope during colonoscopy, highlighting possible polyps.
News
Low-risk adenomas may not elevate risk of CRC-related death
The authors of the meta-analysis suggested that the screening interval for patients with LRAs be 10 years to match recommendations for patients...
News
Researchers stress importance of second COVID-19 vaccine dose for infliximab users
Significantly lower antibody concentrations seen after a first dose of the Pfizer or AstraZeneca vaccine in users of infliximab vs. vedolizumab...